Innate immunity and its role in type 1 diabetes

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 15, Issue 4, 2008, Pages 326-331

  Zipris, Danny ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Innate immunity; Toll like receptors; Type 1 diabetes

Indexed keywords

ALPHA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR;

AUTOIMMUNITY; BLOOD CELL; CELL FUNCTION; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETES MELLITUS; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; REGULATORY T LYMPHOCYTE; REVIEW; SERUM; ANIMAL; ANIMAL MODEL; IMMUNOLOGY; METABOLISM; MOUSE; RAT; SIGNAL TRANSDUCTION;

ANIMALS; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNITY, NATURAL; MICE; MODELS, ANIMAL; RATS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 55249122121     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283073a46     Document Type: Review

References (57)

1. Srikanta S, Ganda OP, Jackson RA, et al. Type I diabetes mellitus inmonozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med 1983; 99: 320-326.
2. Schranz DB, Lernmark A. Immunology in diabetes: an update. Diabetes Metab Rev 1998; 14:3-29.
3. Seissler J, de Sonnaville JJ, Morgenthaler NG, et al. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Diabetologia 1998; 41:891-897.
4. Soltesz G, Patterson CC, Dahlquist G. Worldwide childhood type 1 diabetes incidence-what can we learn from epidemiology? Pediatr Diabetes 2007; 8 (Suppl 6):6-14.
5. Jun HS, Yoon JW. The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia 2001; 44:271-285.
6. Jun HS, Yoon JW. A new took at viruses in type 1 diabetes. Diabetes-Metabolism Research and Reviews 2003; 19:8-31.
7. Redondo MJ, Yu L, Hawa M, et al. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 2001; 44:354-362.
8. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20:197-216.
9. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449:819-826. A review that addresses the function of the innate and adaptive immune systems in eliminating pathogens.
10. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
11. Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature 2006; 442:39-44.
12. Sansonetti PJ. The innate signaling of dangers and the dangers of innate signaling. Nat Immunol 2006; 7:1237-1242.
13. Brodsky I, Medzhitov R. Two modes of ligand recognition by TLRs. Cell 2007; 130:979-981.
14. Kawai T, Akira S. Signaling to NF-[kappa]B by toll-like receptors. Trends Mol Med 2007; 13:460-469.
15. Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 2007; 220:251-269. A review that focuses on the role of TLR upregulation in triggering autoimmunity.
16. Zipris D, Hillebrands JL, Welsh RM, et al. Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations. J Immunol 2003; 170:3592-3602.
17. Zipris D, Lien E, Xie JX, Greiner DL, et al. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol 2005; 174:131-142.
18. Zipris D, Lien E, Nair A, et al. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat. J Immunol 2007; 178:693-701. Mechanisms of innate-induced T1D in the BBDR rat.
19. Vuckovic S, Withers G, Harris M, et al. Decreased blood dendritic cell counts in type 1 diabetic children. Clin Immunol 2007; 123:281-288.
20. Summers KL, Marleau AM, Mahon JL, et al. Reduced IFN-[alpha] secretion by blood dendritic cells in human diabetes. Clinical Immunology 2006; 121:81-89.
21. Kaizer EC, Glaser CL, Chaussabel D, et al. Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab 2007; 92:3705-3711. Gene profiling in peripheral blood cells from patients with T1D.
22. Devaraj S, Dasu MR, Rockwood J, et al. Increased TLR2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2007; 93:578-583. TLR upregulation in monocytes from patients with T1D.
23. Sherry CL, O'Connor JC, Kramer JM, Freund GG. Augmented lipopolysaccharide-induced TNF-{alpha} production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK. J Immunol 2007; 178:663-670.
24. Mohammad MK, Morran M, Slotterbeck B, et al. Dysregulated toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the nonobese diabetic mouse. Int Immunol 2006; 18:1101-1113.
25. Wang X, Jia S, Geoffrey R, et al. Identification of a molecular signature in human type 1 diabetes mellitus using serumand functional genomics. J Immunol 2008; 180:1929-1937. Sera from newly diagnosed patients with T1D induce proinflammatory pathways in blood cells from healthy subjects.
26. Pascual V, Allantaz F, Arce E, et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005; 201:1479-1486.
27. Raine T, Zaccone P, Mastroeni P, Cooke A. Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes. J Immunol 2006; 177:2224-2233.
28. Alyanakian MA, Grela F, Aumeunier A, et al. Transforming growth factor-{beta} and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes 2006; 55:179-185.
29. Steptoe RJ, Ritchie JM, Harrison LC. Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice. J Immunol 2002; 168:5032-5041.
30. Marleau AM, Singh B. Myeloid dendritic cells in nonobese diabetic mice have elevated costimulatory and T helper-1-inducing abilities. J Autoimmun 2002; 19:23-35.
31. Feili-Hariri M, Morel PA. Phenotypic and functional characteristics of BM-derived DC from NOD and nondiabetes-prone strains. Clinic Immunol 2001; 98:133-142.
32. Gaudreau S, Guindi C, Menard M, et al. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+ CD25+ regulatory T cells. J Immunol 2007; 179:3638-3647. Prevention of diabetes in the NOD mouse by upregulating tolerogenic DCs.
33. Kim HS, Han MS, Chung KW, et al. Toll-like receptor 2 senses [beta]-cell death and contributes to the initiation of autoimmune diabetes. Immunity 2007; 27: 321-333. The role of TLR2 signaling pathway and beta cell death in triggering T1D in the NOD mouse.
34. allois D, Grimm CH, Avner P, et al. The type 1 diabetes locus Idd6 controls TLR1 expression. J Immunol 2007; 179:3896-3903. Involvement of TLR1 pathways in diabetes prevention in the NOD mouse.
35. Lang KS, Recher M, Junt T, et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 2005; 11:138-145.
36. chreuder TCMA, Gelderblom HC, Weegink CJ, et al. High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection. Liver Int 2008; 28:39-46. Evidence for diabetes development in humans following a treatment with IFN-α.
37. Devendra D, Jasinski J, Melanitou E, et al. Interferon-{alpha} as a mediator of polyinosinic:polycytidylic acid-induced type 1 diabetes. Diabetes 2005; 54: 2549-2556.
38. Baccala R, Kono DH, Theofilopoulos AN. Interferons as pathogenic effectors in autoimmunity. Immunol Rev 2005; 204:9-26.
39. Mori H, Shichita T, Yu Q, et al. Suppression of SOCS3 expression in the pancreatic [beta]-cell leads to resistance to type 1 diabetes. Biochem Biophys Res Commun 2007; 359:952-958.
40. Callewaert HI, Gysemans CA, Ladriere L, et al. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection. Diabetes 2007; 56:2169-2173.
41. im S, Kim HS, Chung KW, et al. Essential role for signal transducer and activator of transcription-1 in pancreatic {beta}-cell death and autoimmune type 1 diabetes of nonobese diabetic mice. Diabetes 2007; 56:2561-2568. STAT-1 pathways are involved in diabetes induction in the NOD mouse.
42. Wen L, Peng J, Li Z, Wong FS. The effect of innate immunity on autoimmune diabetes and the expression of toll-like receptors on pancreatic islets. J Immunol 2004; 172:3173-3180.
43. Liu D, Cardozo AK, Darville MI, Eizirik DL. Double-stranded RNA cooperates with interferon-{gamma} and IL-1{beta} to induce both chemokine expression and nuclear factor-{kappa}B-dependent apoptosis in pancreatic {beta}-cells: potential mechanisms for viral-induced insulitis and {beta}-cell death in type 1 diabetes mellitus. Endocrinology 2002; 143:1225-1234.
44. Dogusan Z, Garcia M, Flamez D, et al. Double-stranded RNA induces pancreatic beta cell apoptosis by activation of the TLR3 and IRF-3 pathways. Diabetes 2008; 57:1236-1245. Upregulation of TLR pathways leading to beta cell death.
45. Flodstrom M, Maday A, Balakrishna D, et al. Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 2002; 3:373-382.
46. Hultcrantz M, Huhn MH, Wolf M, et al. Interferons induce an antiviral state in human pancreatic islet cells. Virology 2007; 367:92-101. TLR-induced innate immune upregulation in pancreatic islets.
47. Kato H, Takeuchi O, Sato S, et al. Differential roles ofMDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441:101-105.
48. Rasschaert J, Ladriere L, Urbain M, et al. Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-{gamma}-induced apoptosis in primary pancreatic {beta}-cells. J Biol Chem 2005; 280:33984-33991.
49. Crisa L, Greiner DL, Mordes JP, et al. Biochemical studies of RT6 alloantigens in BB/Wor and normal rats. Evidence for intact unexpressed RT6a structural gene in diabetes-prone BB rats. Diabetes 1990; 39:1279-1288.
50. Rossini AA, Handler ES, Mordes JP, Greiner DL. Human autoimmune diabetes mellitus: lessons from BB rats and NOD mice - caveat emptor. Clin Immunol Immunopathol 1995; 74:2-9.
51. Greiner DL, Rossini AA, Mordes JP. Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor and primum non nocere. Clin Immunol 2001; 100:134-143.
52. Ellerman KE, Richards CA, Guberski DL, et al. Kilham rat triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes 1996; 45:557-562.
53. Jacoby RO, Ball-Goodrich LJ, Besselsen DG, et al. Rodent parvovirus infections. Lab Anim Sci 1996; 46:370-380.
54. Takasawa N, Munakata Y, Ishii KK, et al. Human parvovirus B19 transgenic mice become susceptible to polyarthritis. J Immunol 2004; 173:4675-4683.
55. McKisic MD, Paturzo FX, Gaertner DJ, et al. A nonlethal rat parvovirus infection suppresses rat T lymphocyte effector functions. J Immunol 1995; 155:3979-3986.
56. Chung YH, Jun HS, Son M, et al. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J Immunol 2000; 165: 2866-2876.
57. Liew FY, Xu D, Brint EK, O'Neill LAJ. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005; 5:446-458.